
Japan's Drug Approval Process: A Guide to PMDA & MHLW
Learn about Japan's drug approval process. This guide covers the PMDA & MHLW roles, review timelines, drug lag, and expedited pathways like SAKIGAKE.

Learn about Japan's drug approval process. This guide covers the PMDA & MHLW roles, review timelines, drug lag, and expedited pathways like SAKIGAKE.

Learn about the EU AI Act's impact on pharma. This guide explains the risk-based approach, high-risk AI rules, and compliance steps with a free flowchart & SOP

Understand the ICH M7 guideline for assessing and controlling mutagenic impurities in pharmaceuticals using in silico (Q)SAR software, TTC, and risk-based metho

An explanation of regulatory requirements for audit trails under 21 CFR Part 11 and EU Annex 11, covering automation strategies and data integrity measures.